University of Valencia
Valencia, 46010, Spain
Location contact
José Amengual Lorenzo, Phd
CONTACT
José Amengual-Lorenzo, PhD
PRINCIPAL_INVESTIGATOR
Rubén Agustín-Panader, MsC; PhD
CONTACT
NCT Number: NCT07560761
A prospective, non-randomized, single-arm interventional clinical study with a before-after design will be conducted to assess changes in CIELab color parameters and the Whiteness Index for Dentistry (WID) following a standardized combined dental bleaching protocol. The study aims to evaluate the contribution of the a* parameter (green-red axis) to overall dental whiteness.
Trial opening soon.
Get Notified18 year–65 year
All sexes
Interventional
Not applicable
Valencia, 46010, Spain
José Amengual Lorenzo, Phd
CONTACT
José Amengual-Lorenzo, PhD
PRINCIPAL_INVESTIGATOR
Rubén Agustín-Panader, MsC; PhD
CONTACT
Tooth whitening is one of the most commonly requested aesthetic dental treatments, requiring objective and reproducible methods to quantify color changes. The CIELab color system (L*, a*, b*) and the Whiteness Index for Dentistry (WID) are widely used for this purpose.
While increases in L* and decreases in b* are recognized as the main contributors to dental whitening, the role of the a* parameter remains unclear. Variations in a*, including the presence of negative values or changes in sign during treatment, have been insufficiently studied.
A prospective, non-randomized, single-arm interventional clinical study with a before-after design will be conducted to evaluate changes in L*, a*, b*, and WID following a combined dental bleaching protocol consisting of an in-office phase with hydrogen peroxide and an at-home phase with carbamide peroxide.
Spectrophotometric measurements will be performed at baseline, after the in-office phase, and after completion of the at-home phase. The study will also analyze the relationship between changes in CIELab parameters and WID.
The study will be conducted in accordance with ethical standards and will be approved by the corresponding institutional review board. All participants will provide written informed consent prior to inclusion.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention consists of an in-office bleaching phase with two 20-minute applications of 40% hydrogen peroxide, followed by an at-home bleaching phase using 16% carbamide peroxide applied with custom trays for 90 minutes daily. Treatment will continue until color stabilization is achieved, defined as a change in WID of less than 2.6 units between two consecutive weekly measurements.
Time frame: From baseline to end of treatment (up to 12 weeks).
Change in WID values calculated from CIELab parameters (L*, a*, b*) between baseline and the end of treatment (up to 12 weeks).
Time frame: Baseline to end of treatment (up to 12 weeks).
Difference in L* values between baseline and the end of treatment (up to 12 weeks) measured using spectrophotometry.
Time frame: Baseline to end of treatment (up to 12 weeks).
Difference in a* values between baseline and the end of treatment (up to 12 weeks), including assessment of sign changes.
Time frame: Baseline to end of treatment (up to 12 weeks)
Difference in b* values between baseline and the end of treatment (up to 12 weeks), measured using spectrophotometry.
Time frame: At end of treatment (up to 12 weeks).
Assessment of the relationship between changes in WID and changes in L*, a*, and b*.
Contact information is provided by the study sponsor or research team.
José Amengual-Lorenzo, PhD
CONTACT
Rubén Agustín Panadero, MSc; Phd
CONTACT
University of Valencia
Other
Contribution of the a* Parameter to Dental Bleaching After Combined Bleaching: A Prospective Non-randomized Single-arm Interventional Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737496
Healthy
Changsha, Hunan, China
View Trial DetailsNCT07727785
Healthy
Biberach, Germany
View Trial DetailsNCT07725809
Body Weight, Healthy
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial DetailsNCT07678567
Alcohol Use Disorder, Alcohol-Induced Disorders
Louisville, Kentucky, United States
View Trial Details